Efficacy and Tolerability of Twice-Daily Dosing Schedule of Deferasirox in Transfusion-Dependent Paediatric Beta-Thalassaemia Patients: A Randomized Controlled Study.

Panachiyil, George Mathew; Babu, Tirin; Sebastian, Juny; Ravi, Mandyam Dhati

Panachiyil, George Mathew; Babu, Tirin; Sebastian, Juny; Ravi, Mandyam Dhati.

Afiliación

Panachiyil GM; Department of Clinical Pharmacy, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysore, India.
Babu T; Department of Clinical Pharmacy, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysore, India.
Sebastian J; Department of Clinical Pharmacy, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysore, India.
Ravi MD; Department of Pediatrics, JSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysore, India.

J Pharm Pract ; 36(4): 749-755, 2023 Aug.

Article en En | MEDLINE | ID: mdl-35473439

Asunto(s)

Sobrecarga de Hierro; Talasemia; Talasemia beta; Humanos; Niño; Deferasirox; Talasemia beta/tratamiento farmacológico; Quelantes del Hierro/efectos adversos; Estudios Prospectivos; Benzoatos/efectos adversos; Triazoles/efectos adversos; Ferritinas

Palabras clave

beta-thalassaemia; deferasirox; paediatric patients; serum ferritin; twice-daily dosing

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Talasemia / Talasemia beta / Sobrecarga de Hierro Tipo de estudio: Clinical_trials Límite: Child / Humans Idioma: En Revista: J Pharm Pract Asunto de la revista: FARMACIA Año: 2023 Tipo del documento: Article País de afiliación: India Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google